Showing results (31-40 of 175) with videos related to
Sort By:
Pageof 18
Neuroreport|November 4, 2000
Estimation of striatal dopamine spillover and metabolism in vivoG Yadid, J D Harvey-White, I J Kopin, et al.The New Zealand Medical Journal|March 15, 2006
Coronary artery bypass graft surgery in New Zealand's Auckland region: a comparison between the clinical priority assessment criteria score and the actual clinical priority assignedMary Seddon, Joanna Broad, Sue Crengle, et al.The New Zealand Medical Journal|August 3, 2012
Availability of troponin testing for cardiac patients in New Zealand 2002 to 2011: implications for patient careMohammad Latif, Chris Ellis, Alexei Chataline, et al.Brain Research|March 20, 1999
Kir6.2 oligoantisense administered into the globus pallidus reduces apomorphine-induced turning in 6-OHDA hemiparkinsonian ratsI Lamensdorf, N Meiri, J Harvey-White, et al.The New Zealand Medical Journal|July 21, 2017
30-day mortality after percutaneous coronary intervention in New Zealand public hospitals (ANZACS-QI 18)Andrew Kerr, Michael Ja Williams, Harvey White, et al.American Journal of Physiology. Heart and Circulatory Physiology|June 15, 2007
Endocannabinoids acting at CB1 receptors mediate the cardiac contractile dysfunction in vivo in cirrhotic ratsSándor Bátkai, Partha Mukhopadhyay, Judith Harvey-White, et al.Journal of Neuroscience Research|May 8, 2000
Metabolic stress in PC12 cells induces the formation of the endogenous dopaminergic neurotoxin, 3,4-dihydroxyphenylacetaldehydeI Lamensdorf, G Eisenhofer, J Harvey-White, et al.The New Zealand Medical Journal|September 19, 2013
Maori have worse outcomes after coronary artery bypass grafting than Europeans in New ZealandTom Kai Ming Wang, Tharumenthiran Ramanathan, Ralph Stewart, et al.Brain Research|June 16, 2000
3,4-Dihydroxyphenylacetaldehyde potentiates the toxic effects of metabolic stress in PC12 cellsI Lamensdorf, G Eisenhofer, J Harvey-White, et al.Personalized Medicine|May 20, 2018
A simulation of warfarin maintenance dose requirement using a pharmacogenetic algorithm in an ethnically diverse cohortPatrick Gladding, John Mackay, Irene Zeng, et al.Pageof 18